← FDA Drug Approvals (Drugs@FDA)

RISEDRONATE SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2015-05-18

Drug application

FDA Application #

ANDA203217

Application type

Abbreviated New Drug Application (Generic)

Brand name

RISEDRONATE SODIUM

Generic name

Risedronate Sodium

Active ingredients

RISEDRONATE SODIUM

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

First approval

2015-05-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown